Screener
Hyperfine, Inc. HYPR Q2 2026 earnings
Reported August 6, 2026 · After market close
Revenue$3.9MMiss by $230.8K
EPS-$0.09In line
Revenue estimate$4.1M
EPS estimate-$0.09
“Q2 was another strong quarter for Hyperfine, marked by solid growth in placements and revenue, continued gross margin expansion, disciplined operating expense management, and a strengthened balance sheet. One year into the launch of the next-generation Swoop® system and our entry into the neurology office market, we are seeing broader use across care settings and international markets. We are executing on our strategy to expand MRI access across sites of care, increase the clinical utility of our technology, and broaden our international reach. With record U.S. scan volume, continued momentum across hospital and office settings, and international commercial progress, portable brain MRI is moving from early adoption toward broader mainstream clinical use.”
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$5.1M
EPS estimate-$0.08
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Hyperfine, Inc. report Q2 2026 earnings?
- Hyperfine, Inc. (HYPR) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were Hyperfine, Inc.'s Q2 2026 revenue and EPS?
- Hyperfine, Inc. reported revenue of $3.9M and eps of $-0.09 for Q2 2026.
- Did Hyperfine, Inc. beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $4.1M by $230.8K. EPS beat the consensus estimate of $-0.09 by $0.00.
- How did Hyperfine, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 44.8% from $2.7M a year earlier and eps grew 25.0% from $-0.12.
- Where can I find Hyperfine, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-337963) and the 10-Q periodic report (0001193125-26-338015) directly on SEC EDGAR. The filing index links above go to sec.gov.
